Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Bristol Myers Squibb Completes Acquisition of Forbius

Bristol Myers Squibb announced that it has successfully completed its transaction to acquire Forbius for their TGF-beta program, including its lead investigational asset AVID200, currently in Phase 1 for oncology and fibrosis. “We are pleased to complete the transaction with Forbius and add their TGF-beta program to our growing pipeline of innovative assets,” said Rupert […]

The post Bristol Myers Squibb Completes Acquisition of Forbius first appeared on World Pharma Today.



This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here

Share the post

Bristol Myers Squibb Completes Acquisition of Forbius

×

Subscribe to Leading Pharmaceutical Industry Online Platform

Get updates delivered right to your inbox!

Thank you for your subscription

×